Strata Critical Medical (NASDAQ:SRTA) Short Interest Down 47.9% in June

Strata Critical Medical (NASDAQ:SRTA) was the target of a large decrease in short interest in June. As of June 30th, there was short interest totaling 4,075,056 shares, a decrease of 47.9% from the June 15th total of 7,824,961 shares. Approximately 5.6% of the shares of the stock are short sold. Based on an average daily volume of 1,622,698 shares, the short-interest ratio is currently 2.5 days.

Strata Critical Medical Trading Up 2.2%

Shares of Strata Critical Medical stock traded up $0.12 on Wednesday, hitting $5.39. 327,039 shares of the company traded hands, compared to its average volume of 953,346. Strata Critical Medical has a 12-month low of $3.67 and a 12-month high of $6.50. The company has a market capitalization of $466.83 million, a P/E ratio of -67.44 and a beta of 2.22. The company’s 50-day simple moving average is $5.62.

Strata Critical Medical (NASDAQ:SRTA) last announced its earnings results on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.07. The company had revenue of $67.38 million during the quarter. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. Research analysts forecast that Strata Critical Medical will post -0.14 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently commented on the stock. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a research note on Thursday, March 26th. Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. B. Riley Financial assumed coverage on Strata Critical Medical in a research report on Wednesday, March 25th. They issued a “buy” rating and a $8.00 price objective on the stock. Finally, Craig Hallum started coverage on Strata Critical Medical in a research note on Wednesday, March 25th. They set a “buy” rating and a $8.00 price objective for the company. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Strata Critical Medical has a consensus rating of “Moderate Buy” and an average price target of $8.00.

Insiders Place Their Bets

In other news, CEO Melissa M. Tomkiel sold 29,730 shares of the company’s stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $174,515.10. Following the sale, the chief executive officer directly owned 1,892,774 shares in the company, valued at $11,110,583.38. This represents a 1.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CAO Amir Cohen sold 40,575 shares of the stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $5.91, for a total transaction of $239,798.25. Following the completion of the sale, the chief accounting officer directly owned 151,263 shares in the company, valued at approximately $893,964.33. The trade was a 21.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 116,931 shares of company stock worth $687,184 in the last quarter. 15.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On Strata Critical Medical

Large investors have recently modified their holdings of the company. Dimensional Fund Advisors LP lifted its position in Strata Critical Medical by 11.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 1,617,104 shares of the company’s stock worth $6,759,000 after buying an additional 172,154 shares during the last quarter. Bank of America Corp DE grew its position in Strata Critical Medical by 16.2% during the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock valued at $759,000 after acquiring an additional 25,379 shares during the last quarter. Quantinno Capital Management LP raised its stake in shares of Strata Critical Medical by 98.7% during the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after acquiring an additional 71,155 shares in the last quarter. Principal Financial Group Inc. purchased a new stake in shares of Strata Critical Medical in the 1st quarter valued at $537,000. Finally, Seelaus Asset Management LLC boosted its stake in shares of Strata Critical Medical by 32.7% in the 1st quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock valued at $102,000 after purchasing an additional 6,000 shares in the last quarter. 47.36% of the stock is owned by hedge funds and other institutional investors.

About Strata Critical Medical

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.